close
MENU
Hot Topic Reporting season
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

Australia Business Comings and Goings Economics Investment Law NZ Aviation News Politics Professional Services Property Retail Tech & Innovation

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

NBR View Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Reporting season
Investment
2 mins to read
2

Pacific Edge shares up on new clinical evidence

Company says enhanced test could potentially receive a higher price.

Pacific Edge's half-year revenue doubled to $13.6 million.

NBR Staff Tue, 13 Dec 2022

Dual-listed diagnostics company Pacific Edge is lauding the publication of new clinical evidence which it says shows significant improvements in its Cxbladder tests.

The company today announced that a study of 804 patients had found that adding DNA biomarkers to its Cxbladder Triage (CxbT) and

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
NBR Staff Tue, 13 Dec 2022
Contact the Writer: editor@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Pacific Edge Cxbladder Peter Meintjes
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment
3

‘No news is good news’: Pacific Edge on reimbursement uncertainty
Quick Takes

Quick Takes of the Week
Investment
3

‘Worst-case scenario this is a bump in the road’: Pacific Edge
Investment
4

Pacific Edge's share price plummets after trading halt lifted
Comings and Goings

Pacific Edge appoints chief operating officer
Investment
2

Pacific Edge revenue up but loss widens, new CEO lays out plans
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Investment
3

‘No news is good news’: Pacific Edge on reimbursement uncertainty
Quick Takes

Quick Takes of the Week
Investment
3

‘Worst-case scenario this is a bump in the road’: Pacific Edge
Investment
4

Pacific Edge's share price plummets after trading halt lifted
Comings and Goings

Pacific Edge appoints chief operating officer
Investment
2

Pacific Edge revenue up but loss widens, new CEO lays out plans
Pacific Edge shares up on new clinical evidence
Investment,
97066
true
Subscribe Login